Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-07-01 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2021年第一次临时股东大会会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2021 first extraordinary general meeting (临时股东大会) of Guangzhou Yangpu Medical Technology Co., Ltd. It includes voting results, attendance details, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, but rather the official disclosure of voting outcomes and meeting proceedings. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and is a formal announcement of meeting results, not a full report or presentation.
2021-07-01 Chinese
广东华商律师事务所关于广州阳普医疗科技股份有限公司的关注函回复的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by Guangdong Huashang Law Firm regarding a response to a regulatory inquiry (关注函) from the Shenzhen Stock Exchange's ChiNext Board Management Department. It discusses shareholding, control rights, board composition, management appointments, and the stability of control after a transaction involving Gree Jintou and Guangzhou Yangpu Medical Technology Co., Ltd. The document references specific regulatory rules and legal provisions related to control and shareholding. It is not a financial report, earnings release, or management discussion but a legal opinion related to a regulatory inquiry about control and shareholding. The document is lengthy (7424 characters) and contains detailed legal analysis and opinions, not just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory and compliance documents that do not fit other specific categories.
2021-06-30 Chinese
关于深交所关注函回复的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Guangzhou Yangpu Medical Technology Co., Ltd. responding to a regulatory inquiry from the Shenzhen Stock Exchange regarding a change in control of the company. It discusses shareholding changes, control rights, board composition, management appointments, share pledge status, legal compliance, and insider trading checks. The content focuses on the company's control structure, shareholder agreements, and regulatory compliance related to a significant equity transfer and control change. It does not contain financial statements or earnings data, nor is it a transcript or presentation. It is a regulatory announcement addressing a stock exchange inquiry about control changes and related corporate governance matters. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance documents that do not fit other specific categories.
2021-06-30 Chinese
中证鹏元关于关注广州阳普医疗科技股份有限公司控股股东、实际控制人拟发生变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a credit rating agency (中证鹏元资信评估股份有限公司) regarding a proposed change in the controlling shareholder and actual controller of Guangzhou Yangpu Medical Technology Co., Ltd. It includes details about share transfer agreements, voting rights waivers, and the potential impact on credit ratings. The document is relatively short (1263 characters) and serves as an announcement of a corporate event related to shareholding and control changes, rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. The content fits best under a Regulatory Filing (RNS) as it is a regulatory announcement about shareholding/control changes without being a formal major shareholding notification or management change announcement. Therefore, the classification is RNS with high confidence.
2021-06-30 Chinese
广州阳普医疗科技股份有限公司公司债券2020年度受托管理事务报告(1)
Audit Report / Information Classification · 95% confidence The document is titled as a "2020年度受托管理事务报告" (2020 Annual Trustee Management Affairs Report) for company bonds issued by Guangzhou Yangpu Medical Technology Co., Ltd. It contains detailed financial data for the year 2020, including operating income, profit, assets, liabilities, and cash flows. It also discusses the bond issuance, trustee management duties, credit enhancement mechanisms, debt repayment ability, and bond interest and principal payment status. The document is prepared by the bond trustee (CITIC Securities) and references regulatory frameworks related to company bonds. The content is comprehensive, covering financial performance, bond management, and compliance with bond covenants, which aligns with a detailed report on bond trustee management activities rather than a general annual report or earnings release. It is not a simple announcement or certification but a substantive report with financial and operational data specific to bond management. Therefore, the document fits best into the category of Audit Report / Information (AR), as it is a standalone report related to bond trustee management and financial oversight, distinct from a full Annual Report (10-K) or other categories. FY 2020
2021-06-30 Chinese
中信证券股份有限公司关于广州阳普医疗科技股份有限公司详式权益变动报告书之财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed financial advisor's verification opinion on a detailed equity change report (详式权益变动报告书) related to Guangzhou Yangpu Medical Technology Co., Ltd. It references specific Chinese securities laws and disclosure standards (e.g., Securities Law, Listing Company Acquisition Management Measures, Disclosure Content and Format Guidelines No. 15 and 16). The document includes extensive due diligence, verification of the equity change report contents, shareholder structure, financial data, and legal compliance. It is not the equity change report itself but a financial advisor's verification opinion on that report. This type of document is a standalone audit or verification report related to an equity change, fitting the category of Audit Report / Information (AR). It is not a simple announcement or a proxy statement, nor a general regulatory filing. The length and detail confirm it is a full report, not just an announcement. Therefore, the classification is AR with high confidence. H1 2021
2021-06-28 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.